Breast Reduction Clinical Trial
Official title:
Reduction of Breast Hypertrophy by Means of Coelioscopique Surgery
The objective of this interventional study is based on the hypothesis that coelioscopique surgery could be used to reduce breast hypertrophy. This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result in the context of reduction of medium volume breast hypertrophy.
Breast reductions are common procedures. One of the main difficulties related to this surgery remains the healing, wide at the peri-areolar level, vertical at the sub-areolar level and in the sub-mammary fold. In addition, this intervention remains subject to the vagaries of hypertrophic or even keloidal healing, especially in young subjects. On This study can be expected to scientifically validate the use of laparoscopic surgery to obtain a clinical result without scarring in the context of the reduction of medium volume breast hypertrophy. Ultimately, the results of this study may serve as a basis for further research by proposing: - Prophylactic mastectomies and immediate breast reconstruction without lateral scar and with a less visible sub-breast scar. - A breast reduction in young patients before the skin undergoes the effects of the heaviness of the breasts. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT03280043 -
Risk of Hematoma After Ketorolac Use in Reduction Mammoplasty.
|
N/A | |
| Completed |
NCT04439396 -
Toradol (Ketorolac) in Breast Surgery to Reduce Pain & Opioid Use
|
Phase 1 | |
| Completed |
NCT00605670 -
Measuring Patient Satisfaction and Quality of Life Following Body Image Altering Surgery
|
N/A | |
| Recruiting |
NCT05891613 -
A Study of Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride Post Breast Reduction
|
Phase 4 |